Anti-CD44v6 (clone BIWA-8P) SynExpress T7-mKa-cJ-X Modified CD8+ T cells

CAT#: ITS-1224-CR1613
Clone: BIWA-8P
Host: Mouse
Cell Source: Modified CD8+ T cells
Species Reactivity: Human
Connector Fragments: T7-mKate-c-Jun-XbaI
Carrier Type: pBR322
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD44v6 (clone BIWA-8P). We employs the pBR322 (T7-mKate-c-Jun-XbaI) vector components and the SynExpress system of the lncRNA Base Editing/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
CD44v6
Clone
BIWA-8P
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mKate
Promoter
T7
Effector Gene
c-Jun
Insertion Sites
XbaI
Gene Modification
Base Editing
Modification Domain
lncRNA
Carrier Type
pBR322
Transformation Accuracy
0.92
Cell Culture
Suspension Culture
Target
CD44v6
Alternative Names
CD44; CDW44; CSPG8; ECMR-III; HCELL; HUTCH-I; IN; LHR; MC56; MDU2; MDU3; MIC4; Pgp1; CD46 molecule (Indian blood group)
Gene ID
P16070(Human)
UniProt ID
960(Human)
Format
Lyophilized/Liquid
Shipping
All cell products are transported using dry ice, or specialized refrigerated containers to ensure that their temperature remains within an appropriate range. For cell products that are particularly sensitive to temperature, transportation must be carried out in liquid nitrogen tanks to ensure the quality and viability of the products.
Handling Advice
Handle cells in a sterile environment to prevent contamination. Use aseptic techniques when transferring to new media or containers. Follow biosafety regulations for disposing of cell waste.
Storage
Keep cell products in the designated temperature range (usually liquid nitrogen or -80°C) to maintain viability.
For Research Use Only | Not For Clinical Use
Online Inquiry